155Indexed trials
Market Rank #14 · Evidence Tier A
Switzerland
Neuroscience Intelligence
Switzerland neuroscience intelligence: 155 indexed trials, 136 institutions, research score 41.68.
46Recruiting
136Research institutions
41.7Research score
Evidence profile
76Sponsors
22Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 41.7 · Data confidence 100.00 · Evidence 41.7
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons30trials
stroke19trials
alzheimers15trials
epilepsy15trials
multiple_sclerosis14trials
other_neurology12trials
neuro_oncology6trials
other_psychiatry5trials
substance_use5trials
adhd4trials
Leading indexed sponsors
University Hospital, Basel, Switzerland18trials
Insel Gruppe AG, University Hospital Bern14trials
University of Zurich12trials
Merck Sharp & Dohme LLC7trials
University Hospital, Geneva6trials
Hoffmann-La Roche6trials
Novartis Pharmaceuticals4trials
Luzerner Kantonsspital4trials
University of Bern4trials
Pfizer3trials